| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 08/28/2001 | CA2333930A1 Dna sequence encoding the specific and antigenic outer membrane protein of s amonella typhi |
| 08/28/2001 | CA2203443C Hepatitis c virus asialoglycoproteins |
| 08/28/2001 | CA2030554C Mutant microbial .alpha.-amylases with increased thermal, acid, and/or alkaline stability |
| 08/23/2001 | WO2001061356A1 Her-2 binding antagonists |
| 08/23/2001 | WO2001061020A2 Alteration of growth and adaptation under hypoxic conditions |
| 08/23/2001 | WO2001061015A2 Thermostable chimeric nucleic acid polymerases and uses thereof |
| 08/23/2001 | WO2001061013A1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 08/23/2001 | WO2001061010A2 Gtpase activating proteins |
| 08/23/2001 | WO2001061009A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001061006A2 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same |
| 08/23/2001 | WO2001061000A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof |
| 08/23/2001 | WO2001060993A1 Bacterial isolates of the genus klebsiella, and an isomaltulose synthase gene isolated therefrom |
| 08/23/2001 | WO2001060992A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | WO2001060991A2 Human kinases |
| 08/23/2001 | WO2001060977A1 Purple photosynthetic bacteria and health foods |
| 08/23/2001 | WO2001060976A1 Single colonies of myxobacteria cells |
| 08/23/2001 | WO2001060975A2 Gene disruption methodologies in fungi for drug target discovery |
| 08/23/2001 | WO2001060974A2 Method for an extraction of proteins from a single cell |
| 08/23/2001 | WO2001060866A1 Anti-viral conjugate comprising a factor allowing the translocation of a protein across a cell membrane and comprising a single-chain antibody fragment directed against a viral protein |
| 08/23/2001 | WO2001060859A1 Novel proteins and novel genes encoding the same |
| 08/23/2001 | WO2001060852A1 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF |
| 08/23/2001 | WO2001060850A1 Novel compounds |
| 08/23/2001 | WO2001060844A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | WO2001060838A2 Aids ancestral viruses and vaccines |
| 08/23/2001 | WO2001060832A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 08/23/2001 | WO2001012827A3 Method for production of transgenic plants with increased tocopherol content |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001011060A3 Method of isolating secretion signals in lactic acid bacteria and novel secretion signals isolated from lactococcus lactis |
| 08/23/2001 | WO2001010907A3 Therapeutic polypeptides and methods for using same |
| 08/23/2001 | WO2001009341A3 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase |
| 08/23/2001 | WO2001009306A3 Mutant bacterial strains l-lysine production |
| 08/23/2001 | WO2001009300A3 Method for generating cgmmv resistant plants, genetic constructs, and obtained cgmmv-resistant plants |
| 08/23/2001 | WO2001007631A3 Novel glycosyltransferase, the production thereof and its use |
| 08/23/2001 | WO2001007611A3 Novel polynucleotides and method for the use thereof |
| 08/23/2001 | WO2001000842A3 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 08/23/2001 | WO2000078954A3 Human transcriptional regulator proteins |
| 08/23/2001 | WO2000055325A3 Plant centromeres |
| 08/23/2001 | WO1999047639A3 Staphylococcus aureus genes and polypeptides |
| 08/23/2001 | US20010016649 Nucleic acids and polypeptides; for diagnosing chondrosarcoma and for drug screening |
| 08/23/2001 | US20010016647 29 human secreted proteins |
| 08/23/2001 | US20010016354 Amplification of gene expression |
| 08/23/2001 | US20010016350 Polynucleotides |
| 08/23/2001 | US20010016349 Mutant Neisseria; culture product |
| 08/23/2001 | US20010016342 Culturing a filamentous fungus |
| 08/23/2001 | US20010016341 Centrifuging, concentration |
| 08/23/2001 | US20010016340 Antihemophilia agent |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | US20010016332 Genetic engineering |
| 08/23/2001 | US20010016317 Compound which precipitate or denaturing protein |
| 08/23/2001 | US20010016312 Low temperature storage |
| 08/23/2001 | US20010016200 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| 08/23/2001 | US20010016197 Cultivating a fungi of the basidiomycetes in a submerged culture on nutrient media, isolating the biomass of edible mushrooms from the culture broth, and drying at a range of 40-45 degrees celsius |
| 08/23/2001 | DE10004468A1 Allenoxidcyclasegen und dessen Verwendung zum Herstellen von Jasmonsäure Allenoxidcyclasegen and its use for the production of jasmonic acid |
| 08/23/2001 | CA2402440A1 Aids ancestral viruses and vaccines |
| 08/23/2001 | CA2400981A1 Novel proteins and novel genes encoding the same |
| 08/23/2001 | CA2400605A1 Process for extracting single-cell protein material from methanotrophic bacteria |
| 08/23/2001 | CA2400588A1 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | CA2400473A1 Her-2 binding antagonists |
| 08/23/2001 | CA2400360A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400101A1 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | CA2400034A1 Human kinases |
| 08/23/2001 | CA2399137A1 Alteration of growth and adaptation under hypoxic conditions |
| 08/23/2001 | CA2398861A1 Gene disruption methodologies for drug target discovery |
| 08/23/2001 | CA2398825A1 Gtpase activating proteins |
| 08/23/2001 | CA2398628A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, andantagonists thereof |
| 08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
| 08/22/2001 | EP1126033A2 Method for determining the effects of a growth-altering agent on a microbial colony |
| 08/22/2001 | EP1126030A1 Thioredoxin reductase ii |
| 08/22/2001 | EP1126029A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/22/2001 | EP1126028A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 08/22/2001 | EP1126027A1 Cell death inhibition by the caspase-12 activation inhibitor MAGE-3 |
| 08/22/2001 | EP1126024A1 Novel thermostable collagen-digesting enzyme, novel microorganism producing the enzyme and process for producing the enzyme |
| 08/22/2001 | EP1125944A1 Pluraflavin and derivatives thereof, process for making them as well as their use |
| 08/22/2001 | EP1124989A1 Method for determining cancer by determining expression of mage-10 |
| 08/22/2001 | EP1124988A1 Methods of identifying and characterizing mutations within bacterial dna gyrase and fabi |
| 08/22/2001 | EP1124985A1 Biomarkers for oxidative stress |
| 08/22/2001 | EP1124983A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 08/22/2001 | EP1124972A1 VECTOR FOR THE TRANSFORMATION OF $i(PHAFFIA RHODOZYMA) AND PROCESS OF TRANSFORMATION THEREBY |
| 08/22/2001 | EP1124971A1 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use |
| 08/22/2001 | EP1124969A2 Recombinant oleandolide polyketide synthase |
| 08/22/2001 | EP1124968A2 Library of novel "unnatural" natural products |
| 08/22/2001 | EP1124967A1 PLANT-OPTIMIZED POLYNUCLEOTIDES ENCODING APPROXIMATELY 15 kDa AND APPROXIMATELY 45 kDa PESTICIDAL PROTEINS |
| 08/22/2001 | EP1124966A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 08/22/2001 | EP1124965A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124964A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124961A2 Thrombopoietic compounds |
| 08/22/2001 | EP1124958A2 Corticosteroid synthesis-associated genes |
| 08/22/2001 | EP1124957A1 Pholasin |
| 08/22/2001 | EP1124952A2 Therapeutic antiangiogenic endostatin compositions |
| 08/22/2001 | EP1124951A2 Human sorting nexins |
| 08/22/2001 | EP1124949A1 Constructing and screening a dna library of interest in filamentous fungal cells |
| 08/22/2001 | EP1124948A1 Method for generating a gene library |
| 08/22/2001 | EP1124947A2 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism |
| 08/22/2001 | EP1124946A1 Glycosylated proteins having reduced allergenicity |
| 08/22/2001 | EP1124944A2 Mutant luciferase having increased thermostability |
| 08/22/2001 | EP1124942A1 A mixed microbial population designated as jsb 98.0 capable of degrading fecal material of animals |
| 08/22/2001 | EP1124941A1 Process for recovering heterologous polypeptides from bacterial cells |